Valuation: DNA X, Inc.

Market Cap 4.76M 4.25M 3.92M 3.56M 6.68M 451M 6.79M 47.25M 18.61M 236M 17.88M 17.49M 749M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 8.52M 7.61M 7.02M 6.38M 11.96M 807M 12.15M 84.57M 33.31M 423M 32M 31.31M 1.34B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
65.23%
Yield 2024 *
-
Yield 2025 -
1 day-1.88%
1 week-2.79%
Current month-31.22%
1 month-28.47%
6 months-24.70%
Current year-0.32%
1 week 3.04
Extreme 3.0359
3.74
1 month 3.02
Extreme 3.02
4.75
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
13.14
3 years 2.52
Extreme 2.5211
192.6
5 years 2.52
Extreme 2.5211
554.4
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-1.88%-2.79%-75.20%-97.92% 4.76M
+0.63%+1.10%+33.79%+99.87% 5,020B
-4.03%-7.54%+120.00%+211.77% 1,075B
-3.73%-2.20%-44.47%+93.98% 87.9B
-0.68%+14.19%-27.89%-43.65% 9.96B
-0.45%+18.76%-11.10% - 2.88B
-2.05%-9.91%-0.52%-44.48% 2.53B
-10.00%-26.57%-74.75%-75.96% 2.2B
-4.33%-14.01%-28.38%+110.27% 1.62B
-4.21%-19.59%-40.44%+2.32% 1.46B
Average -3.08%-2.10%-14.90%+28.47% 620.33B
Weighted average by Cap. -0.27%+0.20%+47.41%+118.81%

Financials

2024 2025
Net sales 58.3M 52.04M 48.01M 43.62M 81.82M 5.52B 83.08M 578M 228M 2.89B 219M 214M 9.17B -
Net income -33.65M -30.03M -27.71M -25.17M -47.23M -3.19B -47.95M -334M -131M -1.67B -126M -124M -5.29B -20.66M -18.44M -17.01M -15.45M -28.99M -1.96B -29.44M -205M -80.72M -1.03B -77.54M -75.88M -3.25B
Net Debt -5.34M -4.77M -4.4M -4M -7.5M -506M -7.61M -53M -20.88M -265M -20.06M -19.63M -840M 3.76M 3.36M 3.1M 2.81M 5.28M 356M 5.36M 37.32M 14.7M 187M 14.12M 13.82M 591M
Projected Income Statement - Annual - DNA X, Inc.
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-10-22 US$3.140 -1.88% 2,568
26-10-21 US$3.200 +3.56% 10,161
26-10-20 US$3.090 -6.65% 15,244
26-10-19 US$3.310 +1.22% 6,935
26-10-16 US$3.270 +1.24% 12,864

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - DNA X, Inc.
  1. Stock Market
  2. Stocks
  3. SONM Stock